Over 40% Face This Post-Chemo Condition | GLP-1s & Cancer Risk +++++ +++ ++

New Data & Trials Over 40% Face This Post-Chemo Condition https://www.medscape.com/viewarticle/global-data-expose-prevalence-chemotherapy-induced-2025a1000q2a?ecd=mkm_ret_251024_mscpmrk_onc_perspectives_etid_etid7820912&uac=148436CN&impID=7820912 GLP-1s & Cancer Risk: Can This Trial Emulate Reality? https://www.medscape.com/viewarticle/glp-1ras-and-cancer-risk-can-this-latest-trial-emulate-2025a1000q7m?ecd=mkm_ret_251024_mscpmrk_onc_perspectives_etid_etid7820912&uac=148436CN&impID=7820912 New NSCLC Trial Data Reignites Debate https://www.medscape.com/viewarticle/adjuvant-vs-neoadjuvant-therapy-nsclc-which-approach-offers-2025a1000pwl?ecd=mkm_ret_251024_mscpmrk_onc_perspectives_etid_etid7820912&uac=148436CN&impID=7820912 Early-Onset CRC: New Clues https://www.medscape.com/viewarticle/mutational-landscape-study-reveals-clues-early-onset-2025a1000qu6?ecd=mkm_ret_251024_mscpmrk_onc_perspectives_etid_etid7820912&uac=148436CN&impID=7820912 Pancreatic Cancer: Who Should Get Screened? https://www.medscape.com/viewarticle/pancreatic-cancer-who-should-get-screened-2025a1000r64?ecd=mkm_ret_251024_mscpmrk_onc_perspectives_etid_etid7820912&uac=148436CN&impID=7820912 Practice & Professional Challenges Oncologist Grief and the Need for Closure https://www.medscape.com/viewarticle/unacknowledged-grief-oncologists-face-and-need-closure-2025a1000qne?ecd=mkm_ret_251024_mscpmrk_onc_perspectives_etid_etid7820912&uac=148436CN&impID=7820912 Per-Protocol vs ITT: Wrong Analysis Inflates Efficacy https://www.medscape.com/viewarticle/protocol-or-itt-choosing-wrong-population-analyses-inflates-2025a1000qn4?ecd=mkm_ret_251024_mscpmrk_onc_perspectives_etid_etid7820912&uac=148436CN&impID=7820912 Time Burden for Participants in Phase 1 Trials https://www.medscape.com/viewarticle/setting-standard-disclosing-time-commitment-participants-2025a1000nqd?ecd=mkm_ret_251024_mscpmrk_onc_perspectives_etid_etid7820912&uac=148436CN&impID=7820912 Also of Interest CLL: More Protection, More Problems? https://www.medscape.com/viewarticle/cll-more-protection-more-problems-2025a1000l2h?ecd=mkm_ret_251024_mscpmrk_onc_perspectives_etid_etid7820912&uac=148436CN&impID=7820912 This Drug Combo Could Shape the Future of CLL Care https://www.medscape.com/viewarticle/this-drug-combo-future-chronic-lymphocytic-leukemia-care-2025a1000rdh?ecd=mkm_ret_251024_mscpmrk_onc_perspectives_etid_etid7820912&uac=148436CN&impID=7820912